Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PocketScript Uptake Will Be Supported By Pharma Promotion

Executive Summary

PocketScript plans to put over 1,000 prescribing devices in physicians' hands with support from four pharmaceutical companies.

You may also be interested in...



WebMD's Ties To 185,000 Doctors Could Boost Uptake Of Hand-Held Devices

WebMD could receive a marketing boost for its hand-held devices from its relationship with 185,000 physicians through its Medical Manager Health Systems subsidiary.

WebMD's Ties To 185,000 Doctors Could Boost Uptake Of Hand-Held Devices

WebMD could receive a marketing boost for its hand-held devices from its relationship with 185,000 physicians through its Medical Manager Health Systems subsidiary.

Medicaid Rebate Liability Is With Manufacturers, Not PBMs - Express Scripts

Manufacturers, not PBMs, are liable for accurate reporting of "best price" rebates, Express Scripts General Counsel Thomas Boudreau observed during an investor conference call March 8.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035737

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel